600 related articles for article (PubMed ID: 23911347)
21. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
[TBL] [Abstract][Full Text] [Related]
22. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells.
Tao L; Forester SC; Lambert JD
Mol Nutr Food Res; 2014 Apr; 58(4):665-76. PubMed ID: 24249144
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3-Gallate Ameliorates Angiotensin II-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells through the Activation of Nrf2/Caspase-3 Signaling.
Zhou X; Liang L; Zhao Y; Zhang H
J Vasc Res; 2017; 54(5):299-308. PubMed ID: 28942440
[TBL] [Abstract][Full Text] [Related]
24. Pemetrexed induces apoptosis in malignant mesothelioma and lung cancer cells through activation of reactive oxygen species and inhibition of sirtuin 1.
Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
Oncol Rep; 2015 May; 33(5):2411-9. PubMed ID: 25738249
[TBL] [Abstract][Full Text] [Related]
25. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects.
Yamamoto T; Lewis J; Wataha J; Dickinson D; Singh B; Bollag WB; Ueta E; Osaki T; Athar M; Schuster G; Hsu S
J Pharmacol Exp Ther; 2004 Jan; 308(1):317-23. PubMed ID: 14569057
[TBL] [Abstract][Full Text] [Related]
26. Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma.
Volta V; Ranzato E; Martinotti S; Gallo S; Russo MV; Mutti L; Biffo S; Burlando B
PLoS One; 2013; 8(3):e58051. PubMed ID: 23526965
[TBL] [Abstract][Full Text] [Related]
27. Structural Modification of (-)-Epigallocatechin Gallate (EGCG) Shows Significant Enhancement in Mitochondrial Biogenesis.
Ha T; Kim MK; Park KS; Jung W; Choo H; Chong Y
J Agric Food Chem; 2018 Apr; 66(15):3850-3859. PubMed ID: 29514455
[TBL] [Abstract][Full Text] [Related]
28. Cellular determinants involving mitochondrial dysfunction, oxidative stress and apoptosis correlate with the synergic cytotoxicity of epigallocatechin-3-gallate and menadione in human leukemia Jurkat T cells.
Tofolean IT; Ganea C; Ionescu D; Filippi A; Garaiman A; Goicea A; Gaman MA; Dimancea A; Baran I
Pharmacol Res; 2016 Jan; 103():300-17. PubMed ID: 26687095
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
[TBL] [Abstract][Full Text] [Related]
30. Epigallocatechin-3-gallate attenuates microcystin-LR-induced apoptosis in human umbilical vein endothelial cells through activation of the NRF2/HO-1 pathway.
Shi J; Zhang M; Zhang L; Deng H
Environ Pollut; 2018 Aug; 239():466-472. PubMed ID: 29679944
[TBL] [Abstract][Full Text] [Related]
31. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
[TBL] [Abstract][Full Text] [Related]
32. Pifithrin-μ induces necroptosis through oxidative mitochondrial damage but accompanies epithelial-mesenchymal transition-like phenomenon in malignant mesothelioma cells under lactic acidosis.
Lee YJ; Park KS; Heo SH; Nam HS; Cho MK; Lee SH
Arch Pharm Res; 2019 Oct; 42(10):890-901. PubMed ID: 31428976
[TBL] [Abstract][Full Text] [Related]
33. Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells.
Pramanik KC; Boreddy SR; Srivastava SK
PLoS One; 2011; 6(5):e20151. PubMed ID: 21647434
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
Jänne PA; Taffaro ML; Salgia R; Johnson BE
Cancer Res; 2002 Sep; 62(18):5242-7. PubMed ID: 12234991
[TBL] [Abstract][Full Text] [Related]
35. Molecular identification for epigallocatechin-3-gallate-mediated antioxidant intervention on the H2O2-induced oxidative stress in H9c2 rat cardiomyoblasts.
Chen WC; Hsieh SR; Chiu CH; Hsu BD; Liou YM
J Biomed Sci; 2014 Jun; 21(1):56. PubMed ID: 24913014
[TBL] [Abstract][Full Text] [Related]
36. Combination of ascorbate/epigallocatechin-3-gallate/gemcitabine synergistically induces cell cycle deregulation and apoptosis in mesothelioma cells.
Martinotti S; Ranzato E; Parodi M; Vitale M; Burlando B
Toxicol Appl Pharmacol; 2014 Jan; 274(1):35-41. PubMed ID: 24200995
[TBL] [Abstract][Full Text] [Related]
37. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
[TBL] [Abstract][Full Text] [Related]
38. Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane.
Nuvoli B; Camera E; Mastrofrancesco A; Briganti S; Galati R
Free Radic Biol Med; 2018 Feb; 115():266-277. PubMed ID: 29229551
[TBL] [Abstract][Full Text] [Related]
39. Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Chen DD; Dong YG; Liu D; He JG
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):925-32. PubMed ID: 19298531
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
